Mark Identification
DIANTHUS THERAPEUTICS
Serial Number
97436362
Filing Date
May 31, 2022
Trademark by
Classification Information
monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases
Pharmaceuticalsresearch and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases
Computer and Scientific